Array Technologies ARRY 深 沪
等待开盘 10-17 09:30:00 美东时间
3.43
-0.140
-3.92%
华盛通- 最 高3.60
- 今 开3.60
- 成交量 2218.00万股
- 最 低 3.34
- 昨 收 3.57
- 总市值 5.28亿
- 52周最高 12.23
- 市盈率 静 --
- 换手率 14.40%
- 52周最低 3.32
- 委 比 -59.56%
- 总股本 1.54亿
- 历史最高 54.78
- 量 比 3.12
- 振 幅 7.28%
- 历史最低 3.32
- 每 手 1
- 风险率 2.09%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Array Technologies收跌3.92%，成交额7651.16万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
今天 06:07
美股大行评级 | 潜在涨幅279.75%！Jones Trading维持Contineum Therapeutics(CTNM)"买入"评级，目标价上调至30美元
今日重点评级关注：Jones Trading：维持Contineum Therapeutics"买入"评级，目标价从24美元升至30美元；StoneX：维持Forum Markets"投机性买入"评级，目标价从9美元升至12美元
10-16 12:30
This Walmart Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst David George upgraded Bank of America Corporation (NYSE:BAC) from Neutral to Outper...
10-15 20:22
Barclays Maintains Equal-Weight on Array Technologies, Lowers Price Target to $4
Barclays analyst Christine Cho maintains Array Technologies (NASDAQ:ARRY) with a Equal-Weight and lowers the price target from $8 to $4.
10-13 23:50
美股大行评级 | 潜在涨幅600.93%！Ascendiant Capital上调Aytu BioPharma目标价至15美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从14.5美元升至15美元；摩根大通：维持Annexon"超配"评级，目标价从14美元升至15美元
10-01 19:18
Piper Sandler Maintains Neutral on Array Technologies, Lowers Price Target to $4
Piper Sandler analyst Dimple Gosai maintains Array Technologies (NASDAQ:ARRY) with a Neutral and lowers the price target from $5 to $4.
09-30 20:03
美股大行评级 | 奈飞遭看淡至57美元！现价仍有两成下行空间；Xenon制药遭多家机构降目标价，最低看至46美元
今日重点评级关注：康托·菲茨杰拉德：维持Abeona Therapeutics"超配"评级，目标价从28美元升至30美元；HC Wainwright & Co.：维持Oculis Holding"买入"评级，目标价从26美元升至39美元
09-21 16:25
UBS Downgrades Array Technologies to Neutral, Lowers Price Target to $5
UBS analyst Jon Windham downgrades Array Technologies (NASDAQ:ARRY) from Buy to Neutral and lowers the price target from $10 to $5.
09-18 21:34
Xenon Pharmaceuticals, Steel Dynamics, Nucor And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 150 points on Friday. Shares of Xenon Pharmaceuticals Inc (NASDAQ:XENE) fell sharply in pre-market trading after the company announced a temporary pause in enrollment for new patients in its ongoing psychiatry st...
09-18 20:01
